Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingosine 1-phosphate receptors (S1PRs) are a family of G protein-coupled receptors (GPCRs) that mediate the effects of the bioactive lipid sphingosine-1-phosphate (S1P). There are five known subtypes: S1PR1, S1PR2, S1PR3, S1PR4, and S1PR5. These receptors play crucial roles in regulating cell proliferation, migration, angiogenesis, immune cell trafficking, cytoskeleton organization, and mitogenesis. Modulators targeting these receptors are used for autoimmune diseases such as relapsing-remitting multiple sclerosis.
Modulators act as functional antagonists after initial agonist-induced internalization on lymphocytes, reducing circulating immune cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingosine 1-phosphate Receptor (S1PR).